Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results
May 02, 2018 11:30 am UTC| Business
RADNOR, Pa., May 02, 2018 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018
May 02, 2018 11:30 am UTC| Business
DALLAS and FORT WORTH, Texas, May 02, 2018 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...
TC PipeLines, LP Announces 2018 First Quarter Financial Results and Cash Distributions
May 02, 2018 11:30 am UTC| Business
HOUSTON, May 02, 2018 -- TC PipeLines, LP (NYSE:TCP) (the Partnership) today reported first quarter 2018 net income to controlling interests of $96 million and distributable cash flow of $112 million. Additionally, in...
African Gold Group Announces Drill Program at Kobada and Madougou
May 02, 2018 11:30 am UTC| Business
TORONTO, May 02, 2018 -- African Gold Group Inc. (TSX-V:AGG) (“AGG” or the “Company”) is pleased to announce plans for an exploration drill program at both the Kobada gold project located in Mali (the “Kobada Project”)...
Avadel Pharmaceuticals Reports First Quarter 2018 Results
May 02, 2018 11:30 am UTC| Business
NOCTIVA™ launch underway across the U.S. FT 218 granted Orphan Drug Designation Generated revenue of $33.3 million DUBLIN, Ireland, May 02, 2018 -- Avadel Pharmaceuticals plc (NASDAQ:AVDL) today announced its...
Balmoral Continues To Expand Bug Gold Deposit And Nearby Horsefly Zone Down Plunge
May 02, 2018 11:30 am UTC| Business
VANCOUVER, British Columbia, May 02, 2018 -- Balmoral Resources Ltd. (“Balmoral” or the “Company”) (TSX:BAR) (OTCQX:BALMF) today reported that the initial results from the winter 2018 drill program on the Company’s...
May 02, 2018 11:30 am UTC| Business
San Diego, CA, May 02, 2018 -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced it will release first quarter 2018 financial results after the close of...